InMode is benefiting from a growing market for non-invasive plastic surgery, which is expected to grow at a 14% CAGR. The company's strong cash flow, international expansion, and investments in research and marketing are positive indicators for future revenue growth. Additionally, the stock repurchase program and investments in bonds and bank deposits are likely to enhance financial stability and boost the stock price.